A Study of MK0359 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
Information provided by:
First received: June 1, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
A study to test the effect of MK0359 in lessening the symptoms of COPD as compared to salmeterol and placebo.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Resource links provided by NLM:
Further study details as provided by Merck:
Contacts and Locations